← Leaderboards
Jun Yang
University Of Texas Med Br Galveston
$1,809,417
Attributed
$4,323,001
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $934.6K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,323,001 · 3
By mechanism
U01$3,432,501 · 1
R21$890,500 · 2
Top collaborators
- Allan R. Brasier7 shared
- William J. Calhoun5 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Allan R. Brasier$76,022,342
- Alexander Bukreyev$20,278,136
- Xuan-Zheng Peter Shi$4,715,071
- Tian Wang$11,943,039
- Yingxin Zhao$1,712,388
Others in their field
Other Emerging Leaders on “Production”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$451,761,218
- Sonia M Thomas · Research Triangle Institute$451,761,218
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$108,384,076
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
Research focus
ProductionResponseMucous MembranePlayPromoterRespiratory Infection VirusEnhancersMediatingExtrinsic AsthmaNuclearHost DefenseCellsImpairmentRecruitAntiviral ImmunityAdultIrf1 GeneComplexAirway RemodelingChronicEpithelial CellsEpigenetic ProcessBindingRhinovirus
Grant awards (9)
Silencer-enhancer transition dysregulates interleukin-6 in mucosal epithelial cell plasticity$200,000
R21 · FY2025 · AI · contact PI
Silencer-enhancer transition dysregulates interleukin-6 in mucosal epithelial cell plasticity$240,000
R21 · FY2024 · AI · contact PI
Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma$681,203
U01 · FY2023 · AI
Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA$197,750
R21 · FY2023 · AI · contact PI
Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma$682,362
U01 · FY2022 · AI
Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma$681,885
U01 · FY2021 · AI
Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA$252,750
R21 · FY2021 · AI · contact PI
Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma$681,806
U01 · FY2020 · AI
Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma$705,245
U01 · FY2019 · AI